BNGO Bionano Genomics, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · bionano.com

1.460USD+0.69%Mkt Cap: 17.19M $P/E: —1d ago

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap17.19M USD

Enterprise Value13.86M USD

Revenue (TTM)30.18M USD

Gross Profit13.19M USD

Net Income (TTM)-26.39M USD

Revenue/Share3.16 USD

Last Price1.460 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees95

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.49

PEG—

EV/EBITDA-0.61

EV/Revenue0.46

P/S0.57

P/B0.54

EPS (TTM)-3.02

EPS (Forward)-0.97

52W Range

1.00040% of range2.150

52W High2.150 USD

52W Low1.000 USD

Profitability

Gross Margin46.25%

Oper. Margin-88.34%

EBITDA Margin-75.12%

Profit Margin-92.59%

ROE-59.42%

ROA-35.87%

Growth

Revenue Growth21.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-16.34M USD

CapEx (TTM)—

FCF Margin7.78%

FCF Yield13.65%

Net Debt-3.21M USD

Net Debt/EBITDA0.14

Balance Sheet

Debt/Equity0.16

Current Ratio2.48

Quick Ratio1.42

Book Value/Sh2.68 USD

Cash/Share0.84 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:60

Split DateJan 27, 2025

Analyst Consensus

Rating—

Target (Mean)5.000 USD

Upside (mean)+242.5%

Target Range4.000 USD – 6.000 USD

4.000+242.5% to mean6.000

# Analysts2

Ownership

Shares Out.11.78M

Float10.64M

Insiders2.76%

Institutions12.95%

Short Interest

Short Ratio0.6d

Short % Float9.72%

Short % Out.9.72%

Shares Short1.14M

Short (prev mo.)1.15M

Technical

SMA 501.319 (+10.7%)

SMA 2001.268 (+15.1%)

Beta1.66

S&P 52W Chg16.45%

Avg Vol (30d)419.49K

Avg Vol (10d)561.92K

Technical Indicators

RSI (14)49.8

MACD0.0592

MACD Signal0.0953

MACD Hist.-0.0360

BB Upper1.947 USD

BB Middle1.525 USD

BB Lower1.102 USD

BB Width55.43%

ATR (14)0.1037 USD

Vol Ratio (20d)0.24x